Tag: Dicerna Pharmaceuticals

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Dicerna Pharmaceuticals

Dicerna Pharmaceuticals (DRNA) Shares Bought by Renaissance Technologies LLC

Added to Collection on: 2018-04-16 19:37:30

Tags for this article:

Health care
Pharmaceuticals policy
Pharmacy
Pharmaceutical industry in China
Science and technology in the People's Republic of China
Pharmaceutical industry of China
Dicerna Pharmaceuticals Inc
Dicerna Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Arbutus Biopharma : Safety and pharmacodynamics of the GalNAc-siRNA AB-729 in subjects with ...

Added to Collection on: 2020-11-15 18:30:00

Tags for this article:

AbbVie
Arrowhead Pharmaceuticals
Biotechnology
Bristol-Myers Squibb
Dicerna Pharmaceuticals
Fujirebio Incorporation
Gilead Sciences
GlaxoSmithKline
Health sciences
Life Sciences
Merck
Merck & Co.
merck sharp and dohme
Pharmaceutical industry
Sysmex Corporation

Click the tags to see associated articles and topics

View Article Details
Dicerna Pharmaceuticals Stock Is Estimated To Be Possible Value Trap

Added to Collection on: 2021-04-25 20:03:45

Tags for this article:

Finance
Economy
Money
Financial capital
Financial ratios
Fundamental analysis
Corporate finance
Return on capital
Valuation
Weighted average cost of capital
Cost of capital
Pharmaceutical industry in China
Dicerna Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Dicerna Pharmaceuticals (DRNA) to Release Earnings on Thursday

Added to Collection on: 2021-04-30 13:41:15

Tags for this article:

Financial markets
Finance
Money
Stock market
Corporate finance
Stock
Short
Price?earnings ratio
NASDAQ
Dicerna Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Dicerna Pharmaceuticals (NASDAQ:DRNA) Earns "Buy" Rating from HC Wainwright

Added to Collection on: 2021-06-23 11:48:45

Tags for this article:

Finance
Money
Economy
Stock market
Valuation
Investment
Financial markets
Corporate finance
Undervalued stock
Short
Price?earnings ratio
Stock
Dicerna Pharmaceuticals
HC Wainwright

Click the tags to see associated articles and topics

View Article Details
Dicerna Pharmaceuticals (NASDAQ:DRNA) PT Raised to $42.00 at HC Wainwright

Added to Collection on: 2021-06-23 11:50:01

Tags for this article:

Financial markets
Finance
Stock market
Financial economics
Equity securities
Corporate finance
Financial ratios
Stock
Short
Dividend
Price?earnings ratio
Penny stock
Dicerna Pharmaceuticals
HC Wainwright

Click the tags to see associated articles and topics

View Article Details
mRNA Emerges as the Newest & Most Potent Technology in Medicine. Market to Witness ...

Added to Collection on: 2021-09-02 15:45:00

Tags for this article:

Nucleic acids
Life Sciences
Branches of biology
RNA
Medical research
BioNTech
Clinical trials
RNA vaccine
RNA therapeutics
COVID-19 vaccine
Messenger RNA
CureVac
Dicerna Pharmaceuticals
Regulus Therapeutics
Sangamo Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Novo to acquire Dicerna for more than $3B amid RNA drug resurgence | BioPharma Dive

Added to Collection on: 2021-11-18 13:23:46

Tags for this article:

Life Sciences
Health sciences
Health care
RNA
Alnylam Pharmaceuticals
Therapeutic gene modulation
Small interfering RNA
Novartis
Patisiran
Arrowhead Pharmaceuticals
Roche
Novo Nordisk
Dicerna Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details